Chih‐Cheng Hsu

1.4k total citations
56 papers, 801 citations indexed

About

Chih‐Cheng Hsu is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Chih‐Cheng Hsu has authored 56 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Psychiatry and Mental health. Recurrent topics in Chih‐Cheng Hsu's work include Dialysis and Renal Disease Management (10 papers), Dementia and Cognitive Impairment Research (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Chih‐Cheng Hsu is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Dementia and Cognitive Impairment Research (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Chih‐Cheng Hsu collaborates with scholars based in Taiwan, United States and Germany. Chih‐Cheng Hsu's co-authors include Chii‐Min Hwu, Fu‐Shun Yen, James Cheng‐Chung Wei, Shang‐Jyh Hwang, Hsing‐Yi Chang, Ted Chen, Wu‐Chang Yang, Chi Pang Wen, Yu-Kang Chang and Jia‐Sin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Chih‐Cheng Hsu

52 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Cheng Hsu Taiwan 16 257 181 163 125 112 56 801
Bixia Gao China 14 281 1.1× 174 1.0× 133 0.8× 203 1.6× 81 0.7× 45 864
Turgay Arınsoy Türkiye 16 323 1.3× 135 0.7× 104 0.6× 216 1.7× 80 0.7× 79 914
Tasheia Floyd United States 3 338 1.3× 105 0.6× 101 0.6× 107 0.9× 53 0.5× 3 830
Reid Whitlock Canada 19 309 1.2× 122 0.7× 94 0.6× 161 1.3× 124 1.1× 50 852
Hae‐Ryong Yun South Korea 21 431 1.7× 103 0.6× 131 0.8× 170 1.4× 96 0.9× 58 1.0k
Sri Lekha Tummalapalli United States 14 312 1.2× 204 1.1× 93 0.6× 117 0.9× 47 0.4× 49 906
Wisit Kaewput Thailand 18 275 1.1× 90 0.5× 127 0.8× 159 1.3× 106 0.9× 90 985
Ross Ward United Kingdom 8 208 0.8× 286 1.6× 91 0.6× 186 1.5× 62 0.6× 18 944
Po Huang Chiang Taiwan 6 524 2.0× 124 0.7× 178 1.1× 194 1.6× 99 0.9× 11 1.1k
Daisuke Ninomiya Japan 17 162 0.6× 95 0.5× 160 1.0× 67 0.5× 123 1.1× 54 616

Countries citing papers authored by Chih‐Cheng Hsu

Since Specialization
Citations

This map shows the geographic impact of Chih‐Cheng Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Cheng Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Cheng Hsu more than expected).

Fields of papers citing papers by Chih‐Cheng Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Cheng Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Cheng Hsu. The network helps show where Chih‐Cheng Hsu may publish in the future.

Co-authorship network of co-authors of Chih‐Cheng Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Cheng Hsu. A scholar is included among the top collaborators of Chih‐Cheng Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Cheng Hsu. Chih‐Cheng Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yen, Fu‐Shun, et al.. (2025). Low birth weight and chronic kidney disease with progression to kidney failure in children. Nephrology Dialysis Transplantation. 40(8). 1550–1558.
3.
4.
Yeh, Yi‐Ting, Fung‐Chang Sung, Ching-Fang Tsai, et al.. (2024). Statin therapy associated mortality in hyperlipidemic dialysis patients with percutaneous coronary intervention for acute myocardial infarction, a retrospective cohort study. Heliyon. 10(21). e39906–e39906. 2 indexed citations
5.
Chen, Chun‐Ming, Wan‐Ting Huang, Sheng‐Feng Sung, Chih‐Cheng Hsu, & Yueh‐Han Hsu. (2024). Statin use associated with a reduced risk of hip fracture in patients with gout. Bone Reports. 22. 101799–101799. 1 indexed citations
6.
Chiu, Ying‐Ming, Wei‐Lieh Huang, Shi‐Heng Wang, et al.. (2024). Estimating expected years of life lost of psychiatric disorders in Taiwan: A Nationwide cohort study. General Hospital Psychiatry. 91. 25–32. 1 indexed citations
7.
8.
Chuang, Shao‐Yuan, Wen‐ling Liu, Hsing‐Yi Chang, Chih‐Cheng Hsu, & Wen‐Harn Pan. (2023). Central obesity and elevated blood pressure in middle life are associated with physical and cognitive impairment in later life: A retrospective design with repeated measures. Experimental Gerontology. 173. 112093–112093. 5 indexed citations
9.
Lee, Chin‐Chan, et al.. (2022). Hospitalization in patients with dialysis in Taiwan: A nationwide population-based observational study. Journal of the Formosan Medical Association. 121. S39–S46. 10 indexed citations
10.
Yen, Fu‐Shun, James Cheng‐Chung Wei, Lu‐Ting Chiu, Chih‐Cheng Hsu, & Chii‐Min Hwu. (2022). Diabetes, hypertension, and cardiovascular disease development. Journal of Translational Medicine. 20(1). 9–9. 48 indexed citations
11.
Yen, Fu‐Shun, James Cheng‐Chung Wei, Lu‐Ting Chiu, Chih‐Cheng Hsu, & Chii‐Min Hwu. (2022). Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease. Frontiers in Pharmacology. 13. 919881–919881. 4 indexed citations
12.
Yang, Chih‐Yu, et al.. (2021). Mortality rate of end-stage kidney disease patients in Taiwan. Journal of the Formosan Medical Association. 121. S12–S19. 25 indexed citations
13.
Yen, Fu‐Shun, James Cheng‐Chung Wei, Hei‐Tung Yip, et al.. (2021). Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan. Hepatology International. 15(1). 179–190. 19 indexed citations
14.
Hsu, Chih‐Cheng, et al.. (2021). Development of the Subjective Cognitive Decline Scale for Mandarin-Speaking Population. American Journal of Alzheimer s Disease & Other Dementias®. 36. 230397469–230397469.
15.
Tseng, Wei‐Cheng, Jia‐Sin Liu, Szu‐Chun Hung, et al.. (2017). Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study. International Journal of Cardiology. 238. 72–78. 25 indexed citations
16.
Hung, Szu‐Chun, Jia‐Sin Liu, Ko‐Lin Kuo, et al.. (2016). Association between Diuretic Use and the Risk of Chronic Dialysis and Death in Patients with Advanced Chronic Kidney Disease. 30(2). 70–78. 1 indexed citations
17.
Lu, Chia‐Wen, Yu‐Kang Chang, Kuen‐Cheh Yang, et al.. (2016). Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly. Medicine. 95(26). e4064–e4064. 21 indexed citations
18.
Chang, Yu‐Kang, Jia‐Sin Liu, Yueh‐Han Hsu, Der‐Cherng Tarng, & Chih‐Cheng Hsu. (2015). Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Medicine. 94(38). e1362–e1362. 25 indexed citations
19.
Hsu, Yueh‐Han, et al.. (2015). Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease. Medicine. 94(23). e936–e936. 20 indexed citations
20.
Tarng, Der‐Cherng & Chih‐Cheng Hsu. (2015). 2014 Annual Report on Chronic Kidney Disease in Taiwan. 29(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bixia Gao Breakdown of academic impact, for papers by Turgay Arınsoy Breakdown of academic impact, for papers by Tasheia Floyd Breakdown of academic impact, for papers by Reid Whitlock Breakdown of academic impact, for papers by Hae‐Ryong Yun Breakdown of academic impact, for papers by Sri Lekha Tummalapalli Breakdown of academic impact, for papers by Wisit Kaewput Breakdown of academic impact, for papers by Ross Ward Breakdown of academic impact, for papers by Po Huang Chiang Breakdown of academic impact, for papers by Daisuke Ninomiya
Rankless by CCL
2026